Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6138275 | 6956714 | F | 6138275-3 | 20090326 | 20090331 | EXP | B0567603A | GLAXOSMITHKLINE | F | Y | 20090331 | MD | SPAIN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6138275 | 1011356975 | PS | TYVERB | 2 | ORAL | 22059 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6138275 | 1011356975 | BREAST CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6138275 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6138275 | BLOOD BILIRUBIN INCREASED |
| 6138275 | METASTASES TO LIVER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |